Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-AnalysisXueqiong Xun, Huiyong Hu, Ruikang Liu et al.|Frontiers in Oncology|2022Cited by 7
Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysisXueqiong Xun, Huiyong Hu, Jun Ai et al.|Frontiers in Pharmacology|2023Cited by 5